Early in the pandemic, most research, including our own, focused on designing drugs that could block the virus's spike protein. This was a logical first step, but as we've seen, the virus is a moving ...
SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could prevent ...
The association of the receptor binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein with human angiotensin-converting enzyme 2 (hACE2) represents the ...
Researchers have identified new host factors that interact with the receptor binding domain of the SARS-CoV-2 spike protein to promote viral entry. This finding offers valuable mechanistic insights ...
SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could prevent ...
An international team of scientists has generated a new ring-shaped protein nanomaterial capable of strongly binding to and ...
New study reveals how lingering spike protein in the brain's borders could explain long-term COVID-19 neurological symptoms and highlight vaccines' protective role. Study: Persistence of spike protein ...
Coronaviruses have already caused three major disease outbreaks, including the Covid-19 pandemic that hit most countries in the world. However, scientists claim that those pathogens are difficult to ...
An international team of scientists has generated a new ring-shaped protein nanomaterial capable of strongly binding to and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback